scholarly journals Adipose-Derived Exosomes as Possible Players in the Development of Insulin Resistance

2021 ◽  
Vol 22 (14) ◽  
pp. 7427
Author(s):  
Arkadiusz Żbikowski ◽  
Agnieszka Błachnio-Zabielska ◽  
Mauro Galli ◽  
Piotr Zabielski
Keyword(s):  
Insulin Resistance ◽  
Adipose Tissue ◽  
Metabolic Disorders ◽  
Biologically Active ◽  
Whole Body ◽  
Secretory Function ◽  
Endocrine Organ ◽  
Actual Knowledge ◽  
Whole Body Metabolism

Adipose tissue (AT) is an endocrine organ involved in the management of energy metabolism via secretion of adipokines, hormones, and recently described secretory microvesicles, i.e., exosomes. Exosomes are rich in possible biologically active factors such as proteins, lipids, and RNA. The secretory function of adipose tissue is affected by pathological processes. One of the most important of these is obesity, which triggers adipose tissue inflammation and adversely affects the release of beneficial adipokines. Both processes may lead to further AT dysfunction, contributing to changes in whole-body metabolism and, subsequently, to insulin resistance. According to recent data, changes within the production, release, and content of exosomes produced by AT may be essential to understand the role of adipose tissue in the development of metabolic disorders. In this review, we summarize actual knowledge about the possible role of AT-derived exosomes in the development of insulin resistance, highlighting methodological challenges and potential gains resulting from exosome studies.

scholarly journals Multiomics reveal unique signatures of human epiploic adipose tissue related to systemic insulin resistance

Gut ◽  
2021 ◽  
pp. gutjnl-2021-324603
Author(s):  
Laura Krieg ◽  
Konrad Didt ◽  
Isabel Karkossa ◽  
Stephan H Bernhart ◽  
Stephanie Kehr ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Adipose Tissue ◽  
Gastric Bypass Surgery ◽  
Whole Body ◽  
Expression Levels ◽  
Entire Cohort ◽  
Fat Depots ◽  
Systemic Insulin Resistance ◽  
Whole Body Metabolism

ObjectiveHuman white adipose tissue (AT) is a metabolically active organ with distinct depot-specific functions. Despite their locations close to the gastrointestinal tract, mesenteric AT and epiploic AT (epiAT) have only scarcely been investigated. Here, we aim to characterise these ATs in-depth and estimate their contribution to alterations in whole-body metabolism.DesignMesenteric, epiploic, omental and abdominal subcutaneous ATs were collected from 70 patients with obesity undergoing Roux-en-Y gastric bypass surgery. The metabolically well-characterised cohort included nine subjects with insulin sensitive (IS) obesity, whose AT samples were analysed in a multiomics approach, including methylome, transcriptome and proteome along with samples from subjects with insulin resistance (IR) matched for age, sex and body mass index (n=9). Findings implying differences between AT depots in these subgroups were validated in the entire cohort (n=70) by quantitative real-time PCR.ResultsWhile mesenteric AT exhibited signatures similar to those found in the omental depot, epiAT was distinct from all other studied fat depots. Multiomics allowed clear discrimination between the IS and IR states in all tissues. The highest discriminatory power between IS and IR was seen in epiAT, where profound differences in the regulation of developmental, metabolic and inflammatory pathways were observed. Gene expression levels of key molecules involved in AT function, metabolic homeostasis and inflammation revealed significant depot-specific differences with epiAT showing the highest expression levels.ConclusionMulti-omics epiAT signatures reflect systemic IR and obesity subphenotypes distinct from other fat depots. Our data suggest a previously unrecognised role of human epiploic fat in the context of obesity, impaired insulin sensitivity and related diseases.

scholarly journals Interactive effects of aging and aerobic capacity on energy metabolism–related metabolites of serum, skeletal muscle, and white adipose tissue

GeroScience ◽  
2021 ◽  
Author(s):  
Haihui Zhuang ◽  
Sira Karvinen ◽  
Timo Törmäkangas ◽  
Xiaobo Zhang ◽  
Xiaowei Ojanen ◽  
...  
Keyword(s):  
Adipose Tissue ◽  
Amino Acid ◽  
White Adipose Tissue ◽  
Aerobic Capacity ◽  
Amino Acid Metabolism ◽  
Acid Metabolism ◽  
Disease Risk ◽  
Whole Body ◽  
Whole Body Metabolism

AbstractAerobic capacity is a strong predictor of longevity. With aging, aerobic capacity decreases concomitantly with changes in whole body metabolism leading to increased disease risk. To address the role of aerobic capacity, aging, and their interaction on metabolism, we utilized rat models selectively bred for low and high intrinsic aerobic capacity (LCRs/HCRs) and compared the metabolomics of serum, muscle, and white adipose tissue (WAT) at two time points: Young rats were sacrificed at 9 months of age, and old rats were sacrificed at 21 months of age. Targeted and semi-quantitative metabolomics analysis was performed on the ultra-pressure liquid chromatography tandem mass spectrometry (UPLC-MS) platform. The effects of aerobic capacity, aging, and their interaction were studied via regression analysis. Our results showed that high aerobic capacity is associated with an accumulation of isovalerylcarnitine in muscle and serum at rest, which is likely due to more efficient leucine catabolism in muscle. With aging, several amino acids were downregulated in muscle, indicating more efficient amino acid metabolism, whereas in WAT less efficient amino acid metabolism and decreased mitochondrial β-oxidation were observed. Our results further revealed that high aerobic capacity and aging interactively affect lipid metabolism in muscle and WAT, possibly combating unfavorable aging-related changes in whole body metabolism. Our results highlight the significant role of WAT metabolism for healthy aging.

scholarly journals Potential Roles of Adipocyte Extracellular Vesicle–Derived miRNAs in Obesity-Mediated Insulin Resistance

2020 ◽  
Author(s):  
Yujeong Kim ◽  
Ok-Kyung Kim
Keyword(s):  
Insulin Resistance ◽  
Type 2 Diabetes ◽  
Adipose Tissue ◽  
Signaling Pathway ◽  
Insulin Signaling ◽  
Metabolic Disorders ◽  
Extracellular Vesicle ◽  
Extracellular Mirnas

ABSTRACT Recently, extracellular microRNAs (miRNAs) from adipose tissue have been shown to be involved in the development of insulin resistance. Here, we summarize several mechanisms explaining the pathogenesis of obesity-induced insulin resistance and associated changes in the expression of obesity-associated extracellular miRNAs. We discuss how miRNAs, particularly miR-27a, miR-34a, miR-141-3p, miR-155, miR210, and miR-222, in extracellular vesicles secreted from the adipose tissue can affect the insulin signaling pathway in metabolic tissue. Understanding the role of these miRNAs will further support the development of therapeutics for obesity and metabolic disorders such as type 2 diabetes.

scholarly journals Obesity, inflammation, and insulin resistance

2014 ◽  
Vol 50 (4) ◽  
pp. 677-692 ◽  
Author(s):  
Luana Mota Martins ◽  
Ana Raquel Soares Oliveira ◽  
Kyria Jayanne Clímaco Cruz ◽  
Francisco Leonardo Torres-Leal ◽  
Dilina do Nascimento Marreiro
Keyword(s):  
Insulin Resistance ◽  
Adipose Tissue ◽  
Biologically Active ◽  
Endocrine Organ ◽  
Adipose Tissue Dysfunction ◽  
Current Review ◽  
Increased Risk ◽  
Anti Inflammatory ◽  
Inflammatory Molecules ◽  
Inflammatory Action

White adipose tissue (WAT) is considered an endocrine organ. When present in excess, WAT can influence metabolism via biologically active molecules. Following unregulated production of such molecules, adipose tissue dysfunction results, contributing to complications associated with obesity. Previous studies have implicated pro- and anti-inflammatory substances in the regulation of inflammatory response and in the development of insulin resistance. In obese individuals, pro-inflammatory molecules produced by adipose tissue contribute to the development of insulin resistance and increased risk of cardiovascular disease. On the other hand, the molecules with anti-inflammatory action, that have been associated with the improvement of insulin sensitivity, have your decreased production. Imbalance of these substances contributes significantly to metabolic disorders found in obese individuals. The current review aims to provide updated information regarding the activity of biomolecules produced by WAT.

scholarly journals RBP4: a controversial adipokine

2011 ◽  
Vol 165 (5) ◽  
pp. 703-711 ◽  
Author(s):  
Primoz Kotnik ◽  
Pamela Fischer-Posovszky ◽  
Martin Wabitsch
Keyword(s):  
Insulin Resistance ◽  
Children And Adolescents ◽  
Biologically Active ◽  
Retinol Binding Protein ◽  
Confounding Factors ◽  
Endocrine Organ ◽  
Retinol Binding Protein 4 ◽  
The Metabolic Syndrome

Adipose tissue is an endocrine organ secreting biologically active factors called adipokines that act on both local and distant tissues. Adipokines have an important role in the development of obesity-related comorbidities not only in adults but also in children and adolescents. Retinol binding protein 4 (RBP4) is a recently identified adipokine suggested to link obesity with its comorbidities, especially insulin resistance, type 2 diabetes (T2D), and certain components of the metabolic syndrome. However, data, especially resulting from the clinical studies, are conflicting. In this review, we summarize up-to-date knowledge on RBP4's role in obesity, development of insulin resistance, and T2D. Special attention is given to studies on children and adolescents. We also discuss the role of possible confounding factors that should be taken into account when critically evaluating published studies or planning new studies on this exciting adipokine.

scholarly journals Role of adipokines and nonesterified fatty acids in the development of insulin resistance

2009 ◽  
Vol 55 (3) ◽  
pp. 13-16 ◽  
Author(s):  
D. A. Tanyanskiy ◽  
E M. Firova ◽  
L. V. Shatilina ◽  
A. D. Denisenko
Keyword(s):  
Insulin Resistance ◽  
Fatty Acids ◽  
Body Weight ◽  
Adipose Tissue ◽  
Regression Analysis ◽  
Linear Regression Analysis ◽  
Biologically Active ◽  
Homa Index ◽  
Nonesterified Fatty Acids

The purpose of the study was to reveal a possible role of adipokines, biologically active adipose tissue proteins (leptin and adiponectin) and nonesterified fatty acids in generating insulin resistance (IR). One hundred and fifty-seven patients (90 females and 67 males) aged 57.5±9.2 years were enrolled in the study. According to the HOMA index for IR, the patients were divided into 3 equal groups. The examinees with a high HOMA index were found to have elevated levels of fatty acids, leptin and decreased concentrations of adiponectin. At the same time according to the linear regression analysis, all these indices are its independent determinants. However, analysis of the data in the groups of patients with different body weight revealed that the increased concentrations of fatty acids and leptin may play a role in the development of IR in subjects with obesity while the higher level of fatty acids and lower adiponectin may be involved in patients without noticeable obesity. Thus, it may be assumed that leptin, adiponectin and nonesterified fatty acids may affect the development of IR; however, their contribution depends on the degree of adiposity.

scholarly journals ENDOCRINE FUNCTION OF ADIPOSE TISSUE (LITERATURE REVIEW)

2021 ◽  
Vol 28 (2) ◽  
pp. 18-25
Author(s):  
Vladimir Georgievich Solovyov ◽  
◽  
Svetlana Petrovna Kalashnikova ◽  
Lyubov Gennadievna Nikonova ◽  
Margarita Albertovna Gagaro
Keyword(s):  
Adipose Tissue ◽  
Metabolic Disorders ◽  
Physiological Role ◽  
Biologically Active ◽  
Endocrine Function ◽  
Systemic Level ◽  
Tissue Sensitivity ◽  
And Storage ◽  
Active Substances

Adipose tissue serves not only as a place for the accumulation and storage of triacylglycerides as energy substrates, but also produces many hormone-like substances, mediators, cytokines, chemokines that act at the local and systemic level and aff ect metabolism, regulate tissue sensitivity to insulin, reproductive and the immune system. The review presents the current results of scientifi c research on the problem of the physiological role of biologically active substances produced by adipose tissue and their participation in the development of metabolic disorders.

scholarly journals The Endocrine Role of Adipose Tissue and Its Management of Obesity-Related Diseases.

2020 ◽  
pp. 1-2
Keyword(s):  
Adipose Tissue ◽  
Fatty Acid Esters ◽  
Whole Body ◽  
Low Grade ◽  
Endocrine Organ ◽  
Hydroxyl Fatty Acids ◽  
Body Energy ◽  
Low Grade Inflammation ◽  
Acid Esters

Adipose tissue plays a central role in regulating whole-body energy. Moreover, adipose tissue acts as an endocrine organ and produces numerous bioactive factors called adipokines which communicate with other organs and modulate a range of metabolic pathways: proteins (adiponectin, angiopoietins, chemerin, etc.), lipids (fatty acid esters of hydroxyl fatty acids, lysophosphatidic acids and sphingolipids), metabolites (uric acid and uridine) and microRNAs. However, excessive adipose tissue is associated with a chronic state of low-grade inflammation, caused by unbalanced production or secretion of these adipokines and can contribute to the development of obesity [1].

scholarly journals Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation

2013 ◽  
Vol 124 (8) ◽  
pp. 491-507 ◽  
Author(s):  
Silvia Bijland ◽  
Sarah J. Mancini ◽  
Ian P. Salt
Keyword(s):  
Insulin Resistance ◽  
Adipose Tissue ◽  
Protein Kinase ◽  
Caloric Intake ◽  
Whole Body ◽  
Acid Oxidation ◽  
Metabolic Dysfunction ◽  
Nutrient Metabolism ◽  
Amp Activated Protein Kinase

AMPK (AMP-activated protein kinase) is a key regulator of cellular and whole-body energy balance. AMPK phosphorylates and regulates many proteins concerned with nutrient metabolism, largely acting to suppress anabolic ATP-consuming pathways while stimulating catabolic ATP-generating pathways. This has led to considerable interest in AMPK as a therapeutic target for the metabolic dysfunction observed in obesity and insulin resistance. The role of AMPK in skeletal muscle and the liver has been extensively studied, such that AMPK has been demonstrated to inhibit synthesis of fatty acids, cholesterol and isoprenoids, hepatic gluconeogenesis and translation while increasing fatty acid oxidation, muscle glucose transport, mitochondrial biogenesis and caloric intake. The role of AMPK in the other principal metabolic and insulin-sensitive tissue, adipose, remains poorly characterized in comparison, yet increasing evidence supports an important role for AMPK in adipose tissue function. Obesity is characterized by hypertrophy of adipocytes and the development of a chronic sub-clinical pro-inflammatory environment in adipose tissue, leading to increased infiltration of immune cells. This combination of dysfunctional hypertrophic adipocytes and a pro-inflammatory environment contributes to insulin resistance and the development of Type 2 diabetes. Exciting recent studies indicate that AMPK may not only influence metabolism in adipocytes, but also act to suppress this pro-inflammatory environment, such that targeting AMPK in adipose tissue may be desirable to normalize adipose dysfunction and inflammation. In the present review, we discuss the role of AMPK in adipose tissue, focussing on the regulation of carbohydrate and lipid metabolism, adipogenesis and pro-inflammatory pathways in physiological and pathophysiological conditions.

scholarly journals ROCK1 isoform-specific deletion reveals a role for diet-induced insulin resistance

2014 ◽  
Vol 306 (3) ◽  
pp. E332-E343 ◽  
Author(s):  
Seung-Hwan Lee ◽  
Hu Huang ◽  
Kangduk Choi ◽  
Dae Ho Lee ◽  
Jianjian Shi ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Adipose Tissue ◽  
Tyrosine Phosphorylation ◽  
Metabolic Regulation ◽  
Rho Kinase ◽  
Inhibitory Effect ◽  
Whole Body ◽  
Obese Mice ◽  
Whole Body Metabolism

Rho kinase (ROCK) isoforms regulate insulin signaling and glucose metabolism negatively or positively in cultured cell lines and skeletal muscle. However, the in vivo function of the ROCK1 isoform in adipose tissue has not been addressed. To determine the specific role of the adipose ROCK1 isoform in the development of insulin resistance and obesity, mice lacking ROCK1 in adipose tissue globally or selectively were studied. Here, we show that insulin's ability to activate IRS-1/PI3K/Akt signaling was greatly enhanced in adipose tissue of ROCK1−/− mice compared with wild-type mice. These effects resulted from the inhibitory effect of ROCK1 on insulin receptor action, as evidenced by the fact that IR tyrosine phosphorylation was abolished in ROCK1−/− MEF cells when ROCK1 was reexpressed. Consistently, adipose-specific disruption of ROCK1 increased IR tyrosine phosphorylation in adipose tissue and modestly improved sensitivity to insulin in obese mice induced by high-fat feeding. This effect is independent of any changes in adiposity, number or size of adipocytes, and metabolic parameters, including glucose, insulin, leptin, and triglyceride levels, demonstrating a minimal effect of adipose ROCK1 on whole body metabolism. Enzymatic activity of ROCK1 in adipose tissue remained ∼50%, which likely originated from the fraction of stromal vascular cells, suggesting involvement of these cells for adipose metabolic regulation. Moreover, ROCK isoform activities were increased in adipose tissue of diet-induced or genetically obese mice. These data suggest that adipose ROCK1 isoform plays an inhibtory role for the regulation of insulin sensitivity in diet-induced obesity in vivo.

Sign in / Sign up

Export Citation Format

Share Document